ATE286717T1 - Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv) - Google Patents

Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv)

Info

Publication number
ATE286717T1
ATE286717T1 AT98950869T AT98950869T ATE286717T1 AT E286717 T1 ATE286717 T1 AT E286717T1 AT 98950869 T AT98950869 T AT 98950869T AT 98950869 T AT98950869 T AT 98950869T AT E286717 T1 ATE286717 T1 AT E286717T1
Authority
AT
Austria
Prior art keywords
biologically active
vesicles
active compound
multilamellar
mlcvs
Prior art date
Application number
AT98950869T
Other languages
English (en)
Inventor
Lawrence T Boni
Michael M Batenjany
Stella Gevantmakher
Mircea C Popescu
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Application granted granted Critical
Publication of ATE286717T1 publication Critical patent/ATE286717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98950869T 1997-10-01 1998-10-01 Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv) ATE286717T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01
PCT/US1998/020780 WO1999016426A2 (en) 1997-10-01 1998-10-01 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds

Publications (1)

Publication Number Publication Date
ATE286717T1 true ATE286717T1 (de) 2005-01-15

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98950869T ATE286717T1 (de) 1997-10-01 1998-10-01 Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv)

Country Status (9)

Country Link
US (1) US6544549B1 (de)
EP (1) EP1019026B1 (de)
JP (1) JP2001517693A (de)
AT (1) ATE286717T1 (de)
AU (1) AU745000B2 (de)
CA (1) CA2305533C (de)
DE (1) DE69828624T2 (de)
IN (1) IN190388B (de)
WO (1) WO1999016426A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006095798A1 (ja) * 2005-03-09 2008-08-14 サンスター株式会社 フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
US7662405B2 (en) * 2005-08-09 2010-02-16 The Research Foundation Of State University Of New York Compositions and methods of preparation of liposomal microparticulate IL-12
WO2008005045A2 (en) 2005-12-30 2008-01-10 Dermazone Solutions, Inc. Nanolipidic particles
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
US9283184B2 (en) 2008-11-24 2016-03-15 Massachusetts Institute Of Technology Methods and compositions for localized agent delivery
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
KR101783068B1 (ko) * 2010-03-19 2017-09-28 메사추세츠 인스티튜트 오브 테크놀로지 지질 소포 조성물 및 사용 방법
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
EP2925297B1 (de) * 2012-11-02 2017-06-21 CyTuVax Zusammensetzung enthaltend zytokin makroaggregate
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
ES2904276T3 (es) 2013-09-27 2022-04-04 Massachusetts Inst Technology Nanoestructuras de proteínas biológicamente activas sin vehículo
AU2016256979B2 (en) 2015-05-04 2021-01-28 Versantis AG Method for preparing transmembrane pH-gradient vesicles
EP3334417A4 (de) 2015-08-12 2019-07-17 Massachusetts Institute of Technology Zelloberflächenkopplung von nanopartikeln
AU2017283480A1 (en) 2016-06-13 2019-01-24 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
EP3678701A4 (de) 2017-09-05 2021-12-01 Torque Therapeutics, Inc. Therapeutische proteinzusammensetzungen und verfahren zur herstellung und verwendung davon
US20200078316A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
US20200188301A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method for Enhancing Passenger Molecule Loading
US20230096704A1 (en) * 2020-02-05 2023-03-30 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
US6312718B1 (en) 1996-02-16 2001-11-06 Biomira Usa, Inc. Vaccine for B-cell malignancies

Also Published As

Publication number Publication date
DE69828624T2 (de) 2005-12-22
WO1999016426A2 (en) 1999-04-08
EP1019026B1 (de) 2005-01-12
CA2305533A1 (en) 1999-04-08
AU9680098A (en) 1999-04-23
DE69828624D1 (de) 2005-02-17
WO1999016426A3 (en) 1999-06-17
US6544549B1 (en) 2003-04-08
EP1019026A2 (de) 2000-07-19
AU745000B2 (en) 2002-03-07
IN190388B (de) 2003-07-26
CA2305533C (en) 2009-12-01
JP2001517693A (ja) 2001-10-09

Similar Documents

Publication Publication Date Title
DE69828624D1 (de) Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv)
ATE341310T1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
NO20013862D0 (no) Fremgangsmate for a regulere liposomstorrelse
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
AU8141891A (en) Unilamellar vesicles
ATE228822T1 (de) Mikroemulsionen zur verwendung als träger zur verabreichung von wirkstoffen
ZA200110000B (en) Novel preparation and administration form comprising an acid-labile active compound.
NZ334561A (en) Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents
DE69614385T2 (de) Verfahren zur herstellung einer liposomen-zubereitung
JP2001517693A5 (de)
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
NO20023139D0 (no) Liposomer som inneholder en forbindelse i supermettet lösning
CA2050679A1 (en) Preparation of liposome and lipid complex compositions
NO970581L (no) Fremgangsmåte for fremstilling av 4-oksoimidazoliniumsalter
KR940703651A (ko) 리포솜 이트라코나졸 제제[liposomal itraconazole formula-tions]
ES2042437T1 (es) Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.
HUT64518A (en) Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
EA200201003A1 (ru) Аморфная модификация торасемида
PT97468A (pt) Processo para a preparacao de suspensoes aquosas de lipossomas contendo em especial derivados iodados ou complexos de gadolinio
WO1998055448A3 (de) Fluoralkencarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende insektizidemittel
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
CA2355779A1 (en) Improved release of medicament active agents from a chewing gum coating
De Armas et al. (25R)-6β-Acetoxy-3β-bromo-5α-spirostan-23-one
TH58479B (th) สารผสมสำหรับใช้ทางปากต้านแบคทีเรียชนิดลิวพูโลนที่ถูกไฮโดรจีเนตและคงตัว

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties